clinique juge
- Address
- lock Available on a paid plan
Eye Diseases at clinique juge
The site is conducting clinical research in ophthalmology, focused on diabetic macular oedema and neovascular age-related macular degeneration. These studies are designed to assess new treatment approaches that may help preserve vision, reduce treatment burden, and improve overall eye care outcomes.
- Evaluating a new gene therapy approach for neovascular age-related macular degeneration
- Studying a dexamethasone implant regimen for diabetic macular oedema
- Measuring visual acuity and long-term eye health outcomes
This research reflects a strong interest in improving both the effectiveness and convenience of treatment for patients with serious retinal diseases.
Musculoskeletal Diseases
Clinical trials here also cover musculoskeletal research, with a focus on knee osteoarthritis. The goal is to compare treatment options that may help relieve symptoms and improve joint function for people living with this common degenerative condition.
- Comparing platelet-rich plasma and fat-derived cell therapies for symptomatic knee osteoarthritis
- Assessing symptom relief and functional improvement
- Exploring regenerative treatment strategies for joint disease
The work at this Marseille research site shows a balance between advanced eye care studies and innovative approaches in joint health.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1AbbVie Deutschland GmbH & Co. KG1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AbbVie Deutschland GmbH & Co. KG2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in clinique juge
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized Controlled Trial of Intra-Articular PRP, MFAT, and PRP-MFAT for Symptomatic Knee Osteoarthritis Treatment | Centre Hospitalier Regional De Marseille | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ranibizumab | 2 | Unknown | 2024-06-07 | 2025-12-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.